Literature DB >> 9211063

Apolipoprotein C-III gene variation and dyslipidaemia.

P J Talmud1, S E Humphries.   

Abstract

Within the apolipoprotein A-I-C-III-A-IV gene cluster, the Ssti polymorphism in the 3' untranslated region of the apolipoprotein C-III gene is the variant site most consistently and strongly associated with raised plasma triglyceride levels and coronary artery disease. To date the molecular mechanisms that underlie this effect have not been fully identified and variation within the insulin-responsive element of the apolipoprotein C-III proximal promoter cannot entirely explain the Ssti effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211063     DOI: 10.1097/00041433-199706000-00005

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  10 in total

1.  APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Xiaoyun Cheng; Jun Yamauchi; Sojin Lee; Ting Zhang; Zhenwei Gong; Radhika Muzumdar; Shen Qu; H Henry Dong
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

Review 2.  Genetic determinants of plasma triglycerides: impact of rare and common mutations.

Authors:  P J Talmud
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

3.  Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians.

Authors:  Manickaraj AshokKumar; Navaneethan Gnana Veera Subhashini; Ramineni SaiBabu; Arabandi Ramesh; Kotturathu Mammen Cherian; Cyril Emmanuel
Journal:  Mol Biol Rep       Date:  2009-08-22       Impact factor: 2.316

4.  Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.

Authors:  Manjusha Dixit; Gourdas Choudhuri; Rajan Saxena; Balraj Mittal
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

5.  Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

Authors:  Yun-Zi Liu; Xiaoyun Cheng; Ting Zhang; Sojin Lee; Jun Yamauchi; Xiangwei Xiao; George Gittes; Shen Qu; Chun-Lei Jiang; H Henry Dong
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

6.  Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.

Authors:  Yin Ruixing; Li Yiyang; Li Meng; Li Kela; Long Xingjiang; Zhang Lin; Liu Wanying; Wu Jinzhen; Yang Dezhai; Lin Weixiong
Journal:  Lipids Health Dis       Date:  2010-08-17       Impact factor: 3.876

7.  Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes.

Authors:  Zhi-Juan Hu; Lu-Ping Ren; Chao Wang; Bing Liu; Guang-Yao Song
Journal:  Exp Ther Med       Date:  2014-07-07       Impact factor: 2.447

Review 8.  Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies.

Authors:  Israa Dib; Alia Khalil; Racha Chouaib; Yolla El-Makhour; Hiba Noureddine
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

9.  Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.

Authors:  Jun Wang; Chuncui Ye; Sujuan Fei
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

Review 10.  Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis.

Authors:  Yan Li; Chao Li; Jie Gao
Journal:  Meta Gene       Date:  2016-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.